The Institute for Innovation & Valuation in Health Care, InnoValHC, is an independent not-for-profit research organization. It was established by scientists with medical, health economic, and econometric backgrounds, as well as hands-on management experience, to analyse health economic and treatment strategies (see Profile). Learn more about the institute's Purpose and Projects.

News

International Symposium on “Accessibility to High-Value Medicines”

Now online available: Presentation on "Social Willingness to Pay” and the Case for “Social Cost Value Analysis" at the International Symposium on “Accessibility to High-Value Medicines” at the London School of Hygiene & Tropical Medicine in England, on December 6, 2017.

Read more …

20th Annual European ISPOR Congress in Glasgow / Scotland, November 04 - 08, 2017

In addition to five scientific contributions on the current practice and the future of Health Technology Assessments (HTAs), alternatives to the logic of cost effectiveness, new European evidence on the economic value of a statistical life year, and the practice of pharmaceutical expenditure projections, Michael Schlander was interviewed by Cathy Jordan of GalbraithWight, answering questions on topical subjects and controversies in the field of health economics.

Read more …

Recent Scientific Publication on the Budget Impact of Drugs for Rare and Ultrarare Diseases

Now available for download:
A systematic review on the "Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases”.

Read more …

Recent Scientific Presentations at the HTAi 2017 Annual Meeting in Rome / Italy, June 17 – 21, 2017

Now available for download:

Research presentations on "An Update on the Economic Value of a Statistical Life Year in Europe" and "Is NICE in the UK more Innovation-Friendly than IQWiG/GBA in Germany?" at the 2017 HTAi Annual Meeting in Rome / Italy, June 17-21, 2017.

Read more …

Health Technology Assessment (HTA) for Medical Products – How to Cope with the Increasing Regulatory Burden?

Now online available: Presentation on "Health Technology Assessment (HTA) for Medical Products - How to Cope with the Increasing Regulatory Burden?" at the MedTech Dialogue Meeting in Mannheim / Germany, on March 23, 2017.

Read more …